18-36297905-G-A

Variant summary

Our verdict is Uncertain significance. The variant received 1 ACMG points: 2P and 1B. PM2BP4

The NM_001281740.3(FHOD3):​c.70G>A​(p.Glu24Lys) variant causes a missense change. The variant allele was found at a frequency of 0.000000711 in 1,406,652 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).

Frequency

Genomes: not found (cov: 32)
Exomes 𝑓: 7.1e-7 ( 0 hom. )

Consequence

FHOD3
NM_001281740.3 missense

Scores

4
7
8

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 7.12

Publications

0 publications found
Variant links:
Genes affected
FHOD3 (HGNC:26178): (formin homology 2 domain containing 3) The protein encoded by this gene is a member of the diaphanous-related formins (DRF), and contains multiple domains, including GBD (GTPase-binding domain), DID (diaphanous inhibitory domain), FH1 (formin homology 1), FH2 (formin homology 2), and DAD (diaphanous auto-regulatory domain) domains. This protein is thought to play a role in actin filament polymerization in cardiomyocytes. Mutations in this gene have been associated with dilated cardiomyopathy (DCM), characterized by dilation of the ventricular chamber, leading to impairment of systolic pump function and subsequent heart failure. Increased levels of the protein encoded by this gene have been observed in individuals with hypertrophic cardiomyopathy (HCM). Alternative splicing results in multiple transcript variants encoding different isoforms. A muscle-specific isoform has been shown to possess a casein kinase 2 (CK2) phosphorylation site at the C-terminal end of the FH2 domain. Phosphorylation of this site alters its interaction with sequestosome 1 (SQSTM1), and targets this isoform to myofibrils, while other isoforms form cytoplasmic aggregates. [provided by RefSeq, Aug 2015]
FHOD3 Gene-Disease associations (from GenCC):
  • cardiomyopathy, familial hypertrophic, 28
    Inheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics
  • hypertrophic cardiomyopathy
    Inheritance: AD Classification: MODERATE Submitted by: Illumina

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Uncertain_significance. The variant received 1 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.37097532).

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
FHOD3NM_001281740.3 linkc.70G>A p.Glu24Lys missense_variant Exon 1 of 29 ENST00000590592.6 NP_001268669.1 Q2V2M9-4

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
FHOD3ENST00000590592.6 linkc.70G>A p.Glu24Lys missense_variant Exon 1 of 29 1 NM_001281740.3 ENSP00000466937.1 Q2V2M9-4
FHOD3ENST00000257209.8 linkc.70G>A p.Glu24Lys missense_variant Exon 1 of 25 1 ENSP00000257209.3 Q2V2M9-3
FHOD3ENST00000359247.8 linkc.70G>A p.Glu24Lys missense_variant Exon 1 of 24 1 ENSP00000352186.3 Q2V2M9-1
FHOD3ENST00000589114.5 linkn.189G>A non_coding_transcript_exon_variant Exon 1 of 14 2

Frequencies

GnomAD3 genomes
Cov.:
32
GnomAD4 exome
AF:
7.11e-7
AC:
1
AN:
1406652
Hom.:
0
Cov.:
31
AF XY:
0.00
AC XY:
0
AN XY:
695466
show subpopulations
African (AFR)
AF:
0.0000324
AC:
1
AN:
30882
American (AMR)
AF:
0.00
AC:
0
AN:
37484
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
25054
East Asian (EAS)
AF:
0.00
AC:
0
AN:
35776
South Asian (SAS)
AF:
0.00
AC:
0
AN:
79456
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
49120
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5688
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
1084952
Other (OTH)
AF:
0.00
AC:
0
AN:
58240
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.575
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
Cov.:
32

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

Inborn genetic diseases Uncertain:1
Dec 18, 2023
Ambry Genetics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

The c.70G>A (p.E24K) alteration is located in exon 1 (coding exon 1) of the FHOD3 gene. This alteration results from a G to A substitution at nucleotide position 70, causing the glutamic acid (E) at amino acid position 24 to be replaced by a lysine (K). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
0.74
BayesDel_addAF
Benign
-0.048
T
BayesDel_noAF
Benign
-0.31
CADD
Pathogenic
27
DANN
Uncertain
1.0
DEOGEN2
Benign
0.30
.;.;T
Eigen
Uncertain
0.46
Eigen_PC
Uncertain
0.43
FATHMM_MKL
Uncertain
0.93
D
LIST_S2
Pathogenic
0.98
D;D;D
M_CAP
Pathogenic
0.58
D
MetaRNN
Benign
0.37
T;T;T
MetaSVM
Benign
-0.82
T
MutationAssessor
Uncertain
2.6
M;M;M
PhyloP100
7.1
PrimateAI
Pathogenic
0.93
D
PROVEAN
Uncertain
-2.4
N;.;N
REVEL
Benign
0.20
Sift
Benign
0.037
D;.;D
Sift4G
Uncertain
0.030
D;D;D
Polyphen
1.0
D;.;P
Vest4
0.34
MutPred
0.27
Gain of methylation at E24 (P = 0.0067);Gain of methylation at E24 (P = 0.0067);Gain of methylation at E24 (P = 0.0067);
MVP
0.13
MPC
2.6
ClinPred
0.99
D
GERP RS
3.2
PromoterAI
0.068
Neutral
Varity_R
0.30
gMVP
0.65
Mutation Taster
=77/23
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

hg19: chr18-33877868; API